Abstract:Myocardial ischemia/reperfusion injury (MIRI) is a significant challenge in the management of myocardial ischemic disease. Extensive evidence suggests that the macrophage‐mediated inflammatory response may play a vital role in MIRI. Mesenchymal stem cells and, in particular, exosomes derived from these cells, may be key mediators of myocardial injury and repair. However, whether exosomes protect the heart by regulating the polarization of macrophages and the exact mechanisms involved are poorly understood. The present study aimed to determine whether exosomes secreted by bone marrow mesenchymal stem cells (BMSC‐Exo) harboring miR‐25‐3p can alter the phenotype of macrophages by affecting the JAK2/STAT3 signaling pathway, which reduces the inflammatory response and protects against MIRI. An in vivo MIRI model was established in rats by ligating the anterior descending region of the left coronary artery for 30 min followed by reperfusion for 120 min, and BMSC‐Exo carrying miR‐25‐3p (BMSC‐Exo‐25‐3p) were administered through tail vein injection. A hypoxia‐reoxygenation model of H9C2 cells was established, and the cells were cocultured with BMSC‐Exo‐25‐3p in vitro . The results of the present study demonstrated that BMSC‐Exo or BMSC‐Exo‐25‐3p could be taken up by cardiomyocytes in vivo and H9C2 cells in vitro . BMSC‐Exo‐25‐3p demonstrated powerful cardioprotective effects by decreasing the cardiac infarct size, reducing the incidence of malignant arrhythmias and attenuating myocardial enzyme activity, as indicated by lactate dehydrogenase and creatine kinase levels. It induced M1‐like macrophage polarization after myocardial ischemia/reperfusion (I/R), as evidenced by the increase in iNOS expression through immunofluorescence staining and upregulation of proinflammatory cytokines through RT‐qPCR, such as interleukin‐1β (IL‐1β) and interleukin‐6 (IL‐6). As hypothesized, BMSC‐Exo‐25‐3p inhibited M1‐like macrophage polarization and proinflammatory cytokine expression while promoting M2‐like macrophage polarization. Mechanistically, the JAK2/STAT3 signaling pathway was activated after I/R in vivo and in LPS‐stimulated macrophages in vitro , and BMSC‐Exo‐25‐3p pretreatment inhibited this activation. The results of the present study indicate that the attenuation of MIRI by BMSC‐Exo‐25‐3p may be related to JAK2/STAT3 signaling pathway inactivation and subsequent inhibition of M1‐like macrophage polarization.

XMU-MP-1 protects heart from ischemia/reperfusion injury in mice through modulating Mst1/AMPK pathway

Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Signal Transduction

Abstract 19689: Kdm3a Protects Myocardium from Ischemia/reperfusion Injury Through Targeting Akt-dependent Signaling Pathways

Mst1 attenuates myocardial ischemia/reperfusion injury following heterotopic heart transplantation in mice through regulating Keap1/Nrf2 axis

Isthmin-1 alleviates cardiac ischemia/reperfusion injury through cGMP-PKG signaling pathway

Isthmin-1 Alleviates Cardiac Ischaemia/reperfusion Injury Through Cgmp-Pkg Signalling Pathway

Xin-Ji-Er-Kang protects heart from ischemia-reperfusion injury by rebalancing lipid metabolism

MicroRNA-146a Protects Against Myocardial Ischaemia Reperfusion Injury by Targeting Med1

MICU1 Protects Against Myocardial Ischemia/reperfusion Injury and Its Control by the Importer Receptor Tom70

Methyl palmitate protects heart against ischemia/reperfusion-induced injury through G-protein coupled receptor 40-mediated activation of the PI3K/AKT pathway

MSCs Modified with HO-1 Gene Transplantation: a Novel Therapeutic Approach for Attenuating Myocardial Ischemia and Reperfusion Injury.

MK-886 protects against cardiac ischaemia/reperfusion injury by activating proteasome-Keap1-NRF2 signalling

Mst1 Promotes Cardiac Ischemia–reperfusion Injury by Inhibiting the ERK-CREB Pathway and Repressing FUNDC1-mediated Mitophagy

BMSC‐derived exosome‐mediated miR‐25‐3p delivery protects against myocardial ischemia/reperfusion injury by constraining M1‐like macrophage polarization

ATPase inhibitory factor 1 protects the heart from acute myocardial ischemia/reperfusion injury through activating AMPK signaling pathway

Protective effect of Xinmai'an tablets via mediation of the AMPK/SIRT1/PGC-1α signaling pathway on myocardial ischemia-reperfusion injury in rats

Mzb1 protects against myocardial infarction injury in mice via modulating mitochondrial function and alleviating inflammation

Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning mediated cardioprotection.

MG53 Protein: A Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury

Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway

AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics